Novo Nordisk’s once-weekly insulin supersedes its once-daily counterparts

cafead

Administrator
Staff member
  • cafead   Jun 26, 2023 at 10:02: AM
via Phase IIIa clinical trials reported more patients achieving target HbA1c with Novo Nordisk’s insulin compared to its once-daily counterparts.

article source